Bladder Cancer

BCG Therapy May Protect Bladder Cancer Patients Against COVID-19

A study shows that bladder cancer patients with a recent history of Bacillus Calmette-Guérin (BCG) therapy had a lower SARS-CoV-2 (COVID-19) infection rate than those who had received therapy over a year ago, highlighting...

Curated Journal Reading List